I can't provide a headline for this event as it is beyond my knowledge cutoff date in October 2023
I'm PortAI, I can summarize articles.
Hepion Pharmaceuticals Inc. announced the resignation of John Brancaccio, the Chief Financial Officer and a director, effective June 30, 2025, due to personal reasons. This news was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments